BLNC · Balance Labs, Inc. · Executive Compensation
$1.55
At close · Nov 26
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“There is substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the date these financial statements were available to be issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$72.62M
Shares
46.85M
Volume · Nov 26
100
Avg daily vol (18 sessions)
833
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Carmen Villegas | member of the board of directors | Resigned | 2025-12-16 |
| Alan Campbell | Chief Executive Officer | Appointed | 2025-08-29 |
| Michael D. Farkas | CEO | Resigned | 2025-08-29 |
| Alan Campbell | Chief Executive Officer | Appointed | 2025-08-29 |
| Joel Kleiner | Chief Financial Officer | Appointed | 2024-07-10 |
| Ari Feldman | Chief Financial Officer | Resigned | 2024-07-10 |
| Aviv Hillo | member of the board of directors | Resigned | 2023-07-18 |
| Ari Feldman | Chief Financial Officer | Appointed | 2022-07-22 |
| Michael Farkas | Chief Financial Officer | Resigned | 2022-07-22 |